We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Ultimovacs ASA (ULTI) NOK1

Sell:68.00 NOK Buy:80.20 NOK Change: 2.30 NOK (3.21%)
Market closed |  Prices as at close on 29 June 2022 | Switch to live prices |
Sell:68.00 NOK
Buy:80.20 NOK
Change: 2.30 NOK (3.21%)
Market closed |  Prices as at close on 29 June 2022 | Switch to live prices |
Sell:68.00 NOK
Buy:80.20 NOK
Change: 2.30 NOK (3.21%)
Market closed |  Prices as at close on 29 June 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Ultimovacs ASA is a Norway-based pharmaceutical company developing immunotherapies against cancer. Ultimovacs’ technology is based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital. Ultimovacs is advancing a broad clinical development program with clinical trials in Europe, Australia and the U.S. The Company's lead product candidate is UV1, a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen telomerase. UV1 is being developed as a therapeutic cancer vaccine which may serve as a platform for use in combination with other immuno-oncology drugs which require an ongoing T cell response for their mode of action.

Contact details

Address:
Ullernchausseen 64
OSLO
0379
Norway
Telephone:
+ ()
Website:
ultimovacs.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ULTI
ISIN:
NO0010851603
Market cap:
2.45 billion NOK
Shares in issue:
34.22 million
Sector:
Biotechnology
Exchange:
Oslo Stock Exchange
Country:
Norway
Currency:
Norwegian Krone
Indices:
Oslo All Share Index

Key personnel


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.